# Ciprofloxacin on Burned Patients

> **NCT00668044** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 18 (actual)

## Conditions studied

- Burns
- Bacterial Infections

## Interventions

- **DRUG:** Ciprofloxacin (BAYO9867)
- **DRUG:** Ciprofloxacin (BAYO9867)

## Key facts

- **NCT ID:** NCT00668044
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2009-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668044, "Ciprofloxacin on Burned Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00668044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*